Industry Assessment of the Contribution of Patient Support Programs, Market Research Programs, and Social Media to Patient Safety

著录项

• 来源
  《Therapeutic innovation & regulatory science.》 |2019年第6期|共10页
• 作者

  Jeremy Jokinen; Dominique Bertin; Bruce Donzanti; Janet Hormbrey; Valerie Simmons; Hal Li; Charles Dharmani; Karolyn Kracht; Thomas S. Hilzinger; Peter Verdru;

  展开▼
• 作者单位

  1grid.431072.30000 0004 0572 4227AbbVie IncNorth ChicagoILUSA;

  2grid.417886.40000 0001 0657 5612Amgen IncThousand OaksCAUSA;

  3grid.418158.10000 0004 0534 4718Genentech IncSouth San FranciscoCAUSA;

  4grid.417993.10000 0001 2260 0793Merck &

  CoKenilworthNJUSA;

  5grid.418786.4Eli Lilly and CompanyWindleshamUnited Kingdom;

  6grid.417993.10000 0001 2260 0793Merck &

  CoKenilworthNJUSA;

  7grid.423286.90000 0004 0507 1326Astellas PharmaNorthbrookILUSA;

  8grid.431072.30000 0004 0572 4227AbbVie IncNorth ChicagoILUSA;

  9grid.422767.2PricewaterhouseCoopersChicagoILUSA;

  10grid.421932.f0000 0004 0605 7243UCBBrusselsBelgium;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 药学;
• 关键词

  pharmacovigilance; adverse events; solicited reports; patient support programs; market research programs; social media;

  机译：药剂编织;不良事件;征求的报告;患者支持计划;市场研究计划;社交媒体;